New president unveiled in pharmaceutical company

X Sign up for free to receive the latest news straight to your inbox Register now The new chairman of pharmaceutical company Burton Clinigen was revealed this morning (September 1). Peter Allen will leave the company and will be replaced as President by Elmar Schnee. Schnee has recently served on …

Read More »

TailorMed’s tough challenge to reform U.S. healthcare

It’s no secret that America’s complicated healthcare system can cause confusion, bureaucratic nightmares, not to mention significant financial burdens on its citizens. It is technically made up of many organizations, usually healthcare providers, insurance companies, independent providers, and hospital systems that all deliver healthcare in their own way. Despite being …

Read More »

New Stroke Rehab Treatment Gets FDA Approval

A new therapy involving vagus nerve stimulation (VNS) combined with rehabilitation has been approved to treat chronic moderate to severe upper limb motor deficits after ischemic stroke, the FDA said Friday. “Today’s approval of the Vivistim Paired VNS System provides the first option for stroke rehabilitation using vagus nerve stimulation,” …

Read More »

Drug decisions for women of childbearing age

Decisions about medication during pregnancy are always a challenge and, since many pregnancies are unplanned, considerations must begin well in advance of pregnancy and must be addressed again if the patient becomes pregnant. Patients with bipolar disorder who discontinue treatment during pregnancy may have a relapse rate of 80% for …

Read More »

Atavistik Bio Announces $ 60 Million Series A Funding to Advance Genetically Validated Targets in Metabolic Diseases and Cancer

CAMBRIDGE, Mass .– (COMMERCIAL THREAD) – Atavistik Bio (“Atavistik”, “Company”), a preclinical biotechnology company pioneering in the identification of metabolite-protein interactions that have the potential to lead to the discovery and development of first-class drug candidates powered by separate allosteric control mechanisms, announced today that the Company has completed a …

Read More »